TNF Pharmaceuticals Inc (TNFA) concluded trading on Wednesday at a closing price of $0.13, with 8.87 million shares of worth about $1.15 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -89.39% during that period and on July 09, 2025 the price saw a gain of about 5.25%. Currently the company’s common shares owned by public are about 14.18M shares, out of which, 13.48M shares are available for trading.
Stock saw a price change of 2.27% in past 5 days and over the past one month there was a price change of -24.82%. Year-to-date (YTD), TNFA shares are showing a performance of -93.02% which decreased to -89.02% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.10 but also hit the highest price of $2.16 during that period. The average intraday trading volume for TNF Pharmaceuticals Inc shares is 4.69 million. The stock is currently trading -7.01% below its 20-day simple moving average (SMA20), while that difference is down -23.17% for SMA50 and it goes to -83.75% lower than SMA200.
TNF Pharmaceuticals Inc (NASDAQ: TNFA) currently have 14.18M outstanding shares and institutions hold larger chunk of about 1.44% of that.
The stock has a current market capitalization of $1.79M and its 3Y-monthly beta is at 1.83. It has posted earnings per share of -$6.95 in the same period. It has Quick Ratio of 1.37 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TNFA, volatility over the week remained 14.02% while standing at 18.26% over the month.
Analysts are in expectations that TNF Pharmaceuticals Inc (TNFA) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same.
